Clinical Trial Update: Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating single-dose SBI-087 in Japanese patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SBI-087

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED